That's true, safety and efficacy are the 2 factors. At least we can assume we get a big tick for safety, this is not a new drug being swallowed/injected, or a device being implanted after all. And from what I've seen of the efficacy (i.e accuracy), the EMU detecting what it's supposed to, we're looking good there too. Far better than the current SOC anyway (i.e. a harried doctor or paramedic making an assessment, or a trip to the big MRI machine in the hospital basement after potentially waiting in the queue for a bit, while million of brain cells die..). I know I'm simplifying things, but sometimes we get lost in the weeds seeing all the problems that could come up, when IMO the likeliest path ahead is approval, commercialisation, improved outcomes for patients, and profit.
Sorry to ramble, I'm just reinvigorated looking back over some of the EMV releases- a damn fine company, and I'm as excited as ever.
Cheers, happy weekend all.
EMV Price at posting:
$2.08 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)